For FQHCs and Tribal Health Programs, CPT 92229 is not simply a per-screen reimbursement question. In most settings, the screening is bundled into the encounter or payment model, which means the financial impact depends on the surrounding visit, the quality measures it helps close, and any value-based or grant requirements tied to screening performance. This page gives a high-level overview of that framework, with the full reimbursement brief available below for teams that need more detailed billing and operational guidance.
Because CPT 92229 is generally bundled into the encounter or payment model at FQHCs and Tribal/IHS facilities, the financial case is not built on a standalone screening fee. It is built on three connected components.
Every diabetic patient referred out for retinal screening is an encounter the health center does not bill. Delivering CPT 92229 in clinic allows FQHCs and Tribal Health Programs to capture qualifying encounters that would otherwise leave the system, while reducing referral leakage and completion barriers.
Point-of-care diabetic retinopathy screening can improve HEDIS Eye Exam for Patients with Diabetes (EED) performance for FQHCs and GPRA diabetic retinopathy screening performance for Tribal and IHS programs. In many environments, these measures are tied to managed care incentives, accountability metrics, and SDPI-related objectives.
For FQHCs in APM and managed care environments, diabetic retinopathy screening performance may affect value-based payment participation and quality incentive eligibility. For Tribal Health Programs, sustained screening performance may support GPRA reporting and SDPI grant competitiveness.
For FQHCs and Tribal Health Programs, billing code CPT 92229 does not generate a separately payable line in the non-standard reimbursement lanes.
It is absorbed into the all-inclusive encounter rate (FQHC PPS or IHS AIR), the per-member-per-month payment (APM / PMPM), or the managed-care contract rate.
This is why a "simple per-screen dollar" number is not the right unit of analysis for either provider type.
Encounter capture is one part of the financial case. Every diabetic patient on the partner organization's panel who would have been referred out to a specialist for screening is now a valuable in-clinic encounter that bills at the FQHC PPS rate or the Tribal IHS AIR. The following rates and ranges apply to in-clinic encounters.
| Setting | Rate | Description |
|---|---|---|
| Medicare FQHC PPS | ~$208 | FQHC PPS rate |
| California Medi-Cal | $220 to $440 | California Medi-Cal range |
| Tribal IHS AIR | ~$729 | Tribal IHS AIR outpatient CY 2025, CY 2026 forthcoming |
This is the operational rule that governs most FQHC and Tribal/IHS conversations about CPT 92229.
Under FQHC PPS and Tribal/IHS AIR billing rules, a qualifying encounter generally requires a face-to-face visit with a recognized provider. A screening-only event performed by non-practitioner staff does not trigger a PPS or AIR encounter on its own (42 CFR 405.2463).
State Medicaid FQHC PPS rules are generally aligned or stricter. Qualifying practitioners may include physicians (MD/DO), nurse practitioners, physician assistants, certified nurse midwives, clinical psychologists, clinical social workers, and dentists for dental encounters.
A screening or diagnostic service delivered by an MA or ophthalmic technician under standing order does not trigger a PPS encounter unless there is a face-to-face encounter with a qualifying practitioner.
CPT 92229 can be delivered during an existing qualifying visit, such as an AWV, chronic care follow-up, problem visit, or diabetes management visit. A dedicated DR screening visit can also qualify when it includes a brief qualifying-practitioner touch.
Although the qualifying encounter rule is broadly similar across FQHC and Tribal settings, the surrounding reimbursement structure can differ significantly. The six environments below summarize how CPT 92229 is incorporated into PPS, managed care, APM/PMPM, Medicare Advantage, and Tribal/IHS AIR models. More detailed lane-by-lane guidance is available in the full reimbursement brief.
Because CPT 92229 is bundled and a screening-only visit does not trigger a PPS or AIR encounter, the most effective approach is to perform diabetic retinopathy screening during an existing qualifying visit. For Medicare-aged patients, the Annual Wellness Visit (AWV) is often the cleanest path.
Your health center identifies diabetic patients due for an AWV, schedules the visit, and completes CPT 92229 during the same encounter. The screening is bundled into the visit, capturing the encounter and closing the diabetic eye-exam gap.
To count as a billable encounter, the screening should be paired with a brief face-to-face with a qualifying practitioner. Dedicated DR screening days can also work if this practitioner touch is included, but the AWV pull-through leverages an existing visit, may include the Medicare AWV adjustment, and supports HEDIS or GPRA quality-measure completion without requiring a separate appointment.